Global Acute Kidney Injury Treatment Market Poised for Remarkable Growth, Forecasted to Reach US$ 3,566.7 Million by 2029 at a 8.2% of CAGR

Acute Kidney Injury Treatment Market
Acute Kidney Injury Treatment Market

The global acute kidney  injury treatment market is expected to develop at a startling 8.2% compound annual growth rate (CAGR) from 2022 to 2029, putting the sector on the verge of substantial expansion. Treatment for acute renal damage is projected to become more in demand in 2022, surpassing a worth of US$ 2,058.2 million. By the end of 2029, the market is likely to rise to US$ 3,566.7 million.

Acute kidney damage, or AKI, is a major global health concern that is typified by an abrupt loss of renal function that can be fatal. The prevalence of AKI is continuously increasing, highlighting the need for efficient treatments and medications as a result of aging populations, a rise in the frequency of chronic diseases, and rising healthcare costs.

Chart New Paths With Your Sample Report :
https://www.futuremarketinsights.com/reports/sample/rep-gb-14403

Key Takeaways:

  • Owing to increasing acute kidney injury prevalence, number of dialysis centres, and efficient treatment method, the dialysis segment is expected to be a significant revenue generator.
  • The intermittent haemodialysis segment, under product, in the acute kidney injury treatment market, is expected to be a prominent segment, as results provided by this treatment are more efficient as compared to other dialysis methods.
  • The pre-renal injury segment is anticipated to dominate the acute kidney injury treatment market, as pre-renal injury is more prevalent in patients with acute kidney injury.
  • North America is expected to dominate the global acute kidney injury treatment market in terms of revenue, owing to the growing adoption of advanced treatments over conventional methods. East Asia is expected to offer lucrative opportunities for the acute kidney injury treatment market during the forecast period.

Advanced Technology & Product Launches – Key Strategies Followed by Manufacturers

The participants in the acute renal injury treatment market are keeping up with advances in diagnostic technology and increased product availability in order to streamline their product offerings in respective regions with different product portfolios. For example, Fresenius Medical Care introduced the 4008A dialysis equipment in January 2022 in an effort to provide accessibility to dialysis treatment that is life-sustaining.

Customization Available:
https://www.futuremarketinsights.com/customization-available/REP-GB-14403

Competitive Landscape:

To provide patients with cutting-edge care, major companies in the worldwide acute renal injury treatment market are concentrating on creating automated, mobile, and tech-driven dialysis equipment. In order to broaden their range of products, they are also using cutting-edge technology like artificial intelligence and the Internet of Things (IoT).

In the meantime, several of the other firms are developing diagnostic technologies to simplify their product offers in emerging markets where their product portfolios are diversified.

For instance:

  • In March 2021, C-Path announced the launch of an acute kidney injury project in partnership with the USA Food and Drug Administration (FDA) for Drug Evaluation and Research, the Office of translational science, and the Division of cardiology and Nephrology, to develop a suite of prognostic tools to improve the detection of drug-induced kidney injury.
  • In June 2021, Abionyxx announced the enrollment of the first patient in its Phase-2a clinical study with CER-001 for the treatment of septic patients at high risk of developing acute kidney injury.

Key Companies Profiled:

  • Novartis, Pfizer Inc.
  • Merck & Co.
  • Biocon Ltd.
  • Teva Pharmaceutical Industries Ltd.
  • Mylan Pharmaceuticals Inc.
  • NIPRO Medical
  • Baxter Corporation
  • Asahi Kasei
  • NIKKISO
  • Fresenius Medical Care
  • Others

Acute Kidney Injury Treatment Market By Category:

Product:

  • Dialysis
    • Intermittent Hemodialysis
    • Continuous Renal Replacement Therapy (CRRT)
    • Sustained Low-Efficiency Dialysis (SLED)
  • Drug Therapy
    • Antibiotics
    • Diuretics
    • Immunosuppressive Agents

Injury:

  • Pre-renal Injury
  • Intrinsic Renal Injury
  • Post-renal Injury

Distribution Channel:

  • Hospitals
  • Ambulatory Surgical Centers
  • Others

Region:

  • North America
  • Latin America
  • Europe
  • South Asia
  • East Asia
  • Oceania
  • Middle East and Africa(MEA)

Gain Full to Market Insights: Purchase Now to Access:
https://www.futuremarketinsights.com/checkout/14403

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 400 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705

For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedInTwitterBlogs | YouTube

Leave a comment

Your email address will not be published. Required fields are marked *